MELT PHARMACEUTICALS
Melt Pharmaceuticals focuses on developing novel approach to providing procedural sedation and analgesia for short-term medical procedures. Its novel and patented, rapidly dissolving sublingual tablet, provides a needle and opioid-free solution for patients and caregivers. Melt Pharmaceuticals was spun out of Harrow Health in January 2019, after successfully completing our Series A financing.
MELT PHARMACEUTICALS
Social Links:
Industry:
Health Care Health Diagnostics Pharmaceutical
Founded:
2019-01-01
Address:
Needham, Massachusetts, United States
Country:
United States
Website Url:
http://www.meltpharma.com
Total Employee:
1+
Status:
Active
Contact:
+1 615 733 4730
Email Addresses:
[email protected]
Total Funding:
11 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Employees Featured
Founder
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-10 | Melt Pharmaceuticals Names Experienced Executive Brad Osborne as Chief Financial Officer |
More informations about "Melt Pharmaceuticals"
Melt Pharmaceuticals - Crunchbase Company Profile โฆ
Contact Email [email protected] Phone Number +1 615 733 4730 Melt Pharmaceuticals focuses on developing novel approach to providing โฆSee details»
Melt Pharmaceuticals - LinkedIn
Melt Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the development and commercialization of patented non-intravenous and non-opioid sedation and โฆSee details»
Corporate Presentation - meltpharma.com
Corporate Presentation - meltpharma.comSee details»
Melt Pharmaceuticals Provides Corporate Update | Business Wire
Jan 3, 2024 Investor Contact: Larry Dillaha, M.D. Chief Executive Officer [email protected] Media Contact: Deb Holliday Holliday Communications, Inc. โฆSee details»
Melt Pharmaceuticals, Inc. (Melt Pharmaceuticals, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ โฆ
Meltโs core intellectual property is the subject of multiple granted patents in North America, Europe, Asia, and the Middle East. Melt Pharmaceuticals, Inc. is a former subsidiary of โฆSee details»
Melt Pharmaceuticals - Overview, News & Similar companies
Jan 3, 2024 Who is Melt Pharmaceuticals. Melt Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the development and commercialization of patented non โฆSee details»
Melt Pharmaceuticals Company Profile 2024: Valuation, Funding ...
Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; US-20240207285-A1: Midazolam and ketamine for enhanced sedation: PendingSee details»
Melt Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Melt Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 25 news, Technology Platform:Small molecule drug ...See details»
Melt Pharmaceuticals, Inc. Company Profile | Brentwood, TN ...
Find company research, competitor information, contact details & financial data for Melt Pharmaceuticals, Inc. of Brentwood, TN. Get the latest business insights from Dun & Bradstreet.See details»
Melt Pharmaceuticals Company Profile: Financials, Valuation, and โฆ
Melt Pharmaceuticals is a privately-held company that develops non-intravenous and non-opioid sedation and analgesia medicines intended for short-duration medical procedures in outpatient โฆSee details»
Melt Pharmaceuticals - Company Profile & Staff Directory
Melt Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the development and commercialization of patented non-intravenous and non-opioid sedation and โฆSee details»
Melt Pharmaceuticals - News, Locations, Executives and โฆ
Usearch has identified 3 executives & key decision-makers. The HQ phone number is (615) 733-4730. The company domain name is meltpharma.com.See details»
Melt Pharmaceuticals Company Profile -Sales, Contacts, โฆ
Melt Pharmaceuticals is in the Drug Stores industry within the Miscellaneous Retail sector and has been in business for approximately 6 years.See details»
Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock ...
Apr 2, 2024 MELT-300 Pivotal Phase 3 Program Topline Readout Expected in Q4 2024. NASHVILLE, Tenn.--(BUSINESS WIRE)--Apr. 2, 2024-- Melt Pharmaceuticals, Inc. (โMeltโ), a โฆSee details»
Melt Pharmaceuticals - Products, Competitors, Financials, โฆ
Headquarters Location. 5511 Virginia Way Suite 300. Brentwood, Tennessee, 37027, United States. 629-802-9555See details»
News Releases - Melt Pharmaceuticals
Jan 3, 2024 Topline Readout Expected in Q4 2024 NASHVILLE, Tenn. --(BUSINESS WIRE)--Jun. 6, 2024-- Melt Pharmaceuticals, Inc. (โMeltโ), a clinical-stage pharmaceutical company โฆSee details»
Melt Pharmaceuticals Company Profile: Overview and Full News โฆ
Meltpharma.com. Overview: Melt Pharmaceuticals. Melt Pharmaceuticals is a Massachusetts-based company that operates in the pharmaceutical industry. The company specializes in the โฆSee details»
Melt Pharmaceuticals Submits INDs for MELTโ210 and MELT-400 โฆ
Company Actively Dosing Patients for Phase 2 Pivotal Efficacy Study for MELT-300; Full Enrollment Followed by Readout on Topline Data Expected by End of Second Quarter of 2022 โฆSee details»
Melt Pharmaceuticals Enters the Clinical Stage of MELT-100
Jul 29, 2020 FDA has accepted MELT-100 IND; Phase 1 study enrollment to start immediately BOSTON, July 29, 2020 (GLOBE NEWSWIRE) -- Melt Pharmaceuticals, Inc., a...See details»
Combination Drugs | Melt Pharmaceuticals
Oct 1, 2019 The Investor Relations website contains information about Melt Pharmaceuticals's business for stockholders, potential investors, and financial analysts.See details»